Condition: Generalized Convulsive Status Epilepticus · Sponsor: Sohag University
About 40% of children with generalized convulsive status epilepticus (GCSE) are not terminated by first-line benzodiazepines (BDZs), and approximately 50% of BDZ-refractory GCSE are not controlled by second-line antiseizure medications. This study investigates the efficacy of ketamine-levetiracetam combination vs. levetiracetam alone for treating children with BDZ-refractory GCSE.
This description comes directly from the study's public registry record.
Elsayed Abdelkreem, MD, PhD · 1114232126 · d.elsayedmohammed@med.sohag.edu.eg
Always discuss trial participation with your own doctor first.
| Department of Pediatrics at Sohag University Hospital | Sohag, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07046611